(Q84511901)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20594876%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

title

Long term follow-up of dogs diagnosed with leishmaniosis (clinical stage II) and treated with meglumine antimoniate and allopurinol (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20594876%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference

meglumine antimoniate

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20594876%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Ivan Ravera

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20594876%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Lluís Ferrer

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20594876%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

author name string

Marta Torres

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20594876%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Xavier Roura

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20594876%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Giordana Zanna

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20594876%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

publication date

1 July 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20594876%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

published in

The Veterinary Journal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20594876%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

volume

188

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20594876%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20594876%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

page(s)

346-351

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20594876%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2010.05.025

Chemotherapy of canine leishmaniosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2010.05.025

Cytokine profiles in canine visceral leishmaniasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2010.05.025

Clinical, serologic, and parasitologic follow-up after long-term allopurinol therapy of dogs naturally infected with Leishmania infantum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2010.05.025

Advantages of real-time PCR assay for diagnosis and monitoring of canine leishmaniosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2010.05.025

Use of allopurinol for maintenance of remission in dogs with leishmaniasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2010.05.025

A randomised, blinded, placebo-controlled clinical trial with allopurinol in canine leishmaniosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2010.05.025

Comparison of different tissue sampling for PCR-based diagnosis and follow-up of canine visceral leishmaniosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2010.05.025

Leishmania DNA quantification by real-time PCR in naturally infected dogs treated with miltefosine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2010.05.025

Real-time PCR assay in Leishmania-infected dogs treated with meglumine antimoniate and allopurinol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2010.05.025

Evidence for a relationship between Leishmania load and clinical manifestations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2010.05.025

Study of efficacy of miltefosine and allopurinol in dogs with leishmaniosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2010.05.025

Multicentric, controlled clinical study to evaluate effectiveness and safety of miltefosine and allopurinol for canine leishmaniosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2010.05.025

The immune response and PBMC subsets in canine visceral leishmaniasis before, and after, chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2010.05.025

Meglumine antimonate directly increases phagocytosis, superoxide anion and TNF-alpha production, but only via TNF-alpha it indirectly increases nitric oxide production by phagocytes of healthy individuals, in vitro.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2010.05.025

Treatment of canine Old World visceral leishmaniasis: a systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2010.05.025

Real-time PCR in dogs treated for leishmaniasis with allopurinol.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2010.05.025

Effects of allopurinol treatment on the progression of chronic nephritis in Canine leishmaniosis (Leishmania infantum)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2010.05.025

Analysis of immune responses in dogs with canine visceral leishmaniasis before, and after, drug treatment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2010.05.025

Diagnosis of canine leishmaniasis by a polymerase chain reaction technique

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2010.05.025

Canine leishmaniosis in the United Kingdom: a zoonotic disease waiting for a vector?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2010.05.025

The effect of intravenous or subcutaneous administration of meglumine antimonate (Glucantime) in dogs with leishmaniasis. A randomized clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2010.05.025

Longitudinal study of dogs living in an area of Spain highly endemic for leishmaniasis by serologic analysis and the leishmanin skin test

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2010.05.025

Directions for the diagnosis, clinical staging, treatment and prevention of canine leishmaniosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2010.05.025

10.1016/J.TVJL.2010.05.025

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20594876%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference